Mucosal immune response in newborn Holstein calves that had maternally derived antibodies and were vaccinated with an intranasal multivalent modified-live virus vaccine

Journal of the American Veterinary Medical Association

Volumn 240, Issue 10, 2012, Pages 1231-1240

  Hill, Kevin L ^a   Hunsaker, Breck D ^b   Townsend, Hugh G ^c,d   Littel van den Hurk, Sylvia van Drunen ^d   Griebel, Philip J ^d,e  

^a Intervet/Schering Plough Animal Health   (United States)

^b Summit Research   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE HERPES VIRUS; CATTLE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MALE; MUCOSAL IMMUNITY; NEWBORN; PASSIVE IMMUNIZATION; RANDOMIZATION; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; CATTLE; DIARRHEA VIRUS 1, BOVINE VIRAL; DIARRHEA VIRUS 2, BOVINE VIRAL; HERPESVIRUS 1, BOVINE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNITY, MUCOSAL; MALE; RANDOM ALLOCATION; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

ANIMALIA; BOVINE HERPESVIRUS 1; BOVINE VIRAL DIARRHEA VIRUS 1; BOVINE VIRAL DIARRHEA VIRUS 2;

EID: 84860671802     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.240.10.1231     Document Type: Article

References (38)

1. Tyler JW, Hancock DD, Thorne JG, et al. Partitioning the mortality risk associated with inadequate passive transfer of colostral immunoglobulins in dairy calves. J Vet Intern Med 1999;13:335-337.
2. Donovan GA, Dohoo IR, Montgomery DM, et al. Associations between passive immunity and morbidity and mortality in dairy heifers in Florida. Prev Vet Med 1998;34:31-46.
3. Chase CC, Hurley DJ, Reber AJ. Neonatal immune development in the calf and its impact on vaccine response. Vet Clin North Am Food Anim Pract 2008;24:87-104.
4. Endsley JJ, Ridpath JF, Neill JD, et al. Induction of T lymphocytes specific for bovine viral diarrhea virus in calves with maternal antibody. Viral Immunol 2004;17:13-23.
5. Chattha KS, Firth MA, Hodgins DC, et al. Age related variation in expression of CD21 and CD32 on bovine lymphocytes: a crosssectional study. Vet Immunol Immunopathol 2009;130:70-78.
6. Pihlgren M, Fulurija A, Villiers MB, et al. Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses. Vaccine 2004;23:329-335.
7. Linscott WD, Triglia RP. The bovine complement system. Adv Exp Med Biol 1981;137:413-430.
8. Tierney TJ, Simpson-Morgan MW. The immune response of foetal calves. Vet Immunol Immunopathol 1997;57:229-238.
9. Ellis J, West K, Cortese V, et al. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med Assoc 2001;219:351-356.
10. Kimman TG, Westenbrink F, Straver PJ. Priming for local and systemic antibody memory responses to bovine respiratory syncytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol 1989;22:145-160.
11. Ellis JA, Gow SP, Goji N. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves. J Am Vet Med Assoc 2010;236:991-999.
12. Lemaire M, Schynts F, Meyer G, et al. Latency and activation of glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies. Vaccine 2001;19:4795-4804.
13. Vangeel I, Antonis AF, Fluess M, et al. Efficacy of a modified live intranasal bovine respiratory syncytial virus vaccine in 3-week-old calves experimentally challenged with BRSV. Vet J 2007;174:627-635.
14. Vangeel I, Ioannou F, Riegler L, et al. Efficacy of an intranasal modified live bovine respiratory syncytial virus and temperaturesensitive parainfluenza type 3 virus vaccine in 3-week-old calves experimentally challenged with PI3V. Vet J 2009;179:101-108.
15. Xue W, Ellis J, Mattick D, et al. Immunogenicity of a modifiedlive virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves. Vaccine 2010;28:3784-3792.
16. Griebel PJ. Mucosal vaccination of the newborn: an unrealized opportunity. Expert Rev Vaccines 2009;8:1-3.
17. Griebel PJ, Hein WR. Expanding the role of Peyer's patches in B-cell ontogeny. Immunol Today 1996;17:30-39.
18. Mutwiri G, Bateman C, Baca-Estrada ME, et al. Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector. Vaccine 2000;19:1284-1293.
19. Gerdts V, Snider M, Brownlie R, et al. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J Immunol 2002;168:1877-1885.
20. Iemura R, Tsukatani R, Micallef MJ, et al. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica. Vet Rec 2009;165:747-751.
21. Jacobs AA, Bergman JG, Theelen RP, et al. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2. Vet Rec 2007;160:41-45.
22. Van Immerseel F, De Buck J, De Smet I, et al. The effect of vaccination with a Salmonella enteritidis aroA mutant on early cellular responses in caecal lamina propria of newly-hatched chickens. Vaccine 2002;20:3034-3041.
23. Tsang CH, Mirakhur KK, Babiuk LA, et al. Oral DNA immunization in the second trimester fetal lamb and secondary immune responses in the neonate. Vaccine 2007;25:8469-8479.
24. Korhonen H, Marnila P, Gill HS. Milk immunoglobulins and complement factors. Br J Nutr 2000;84(suppl 1):S75-S80.
25. Guide for the care and use of agricultural animals in agricultural research and teaching. 3rd ed. Champaign, Ill: Federation of Animal Science Societies, 2010.
26. Hughes HP, Rossow S, Campos M, et al. A slow release formulation for recombinant bovine interferon alpha I-1. Antiviral Res 1994;23:33-44.
27. van Drunen Littel-van den Hurk S, Van Donkersgoed J, Kowalski J, et al. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine 1994;12:1295-1302.
28. Liang R, van den Hurk JV, Landi A, et al. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. J Gen Virol 2008;89:453-466.
29. Butler JE, Frenyo VL, Whipp SC, et al. The metabolism and transport of bovine serum SIgA. Comp Immunol Microbiol Infect Dis 1986;9:303-315.
30. Mach JP, Prahud JJ. Secretory IgA, a major immunoglobulin in most bovine external secretions. J Immunol 1971;106:552-563.
31. Husband AJ, Brandon MR, Lascelles AK. Absorption and endogenous production of immunoglobulins in calves. Aust J Exp Biol Med Sci 1972;50:491-498.
32. Ohmann HB. Pathogenesis of bovine viral diarrhoea-mucosal disease: distribution and significance of BVDV antigen in diseased calves. Res Vet Sci 1983;34:5-10.
33. Potgieter LN. Immunology of bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 1995;11:501-520.
34. Todd JD, Volenec FJ, Paton IM. Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infect Immun 1972;5:699-706.
35. MacLachlan NJ, Rosenquist BD. Duration of protection of calves against rhinovirus challenge exposure by infectious bovine rhinotracheitis virus-induced interferon in nasal secretions. Am J Vet Res 1982;43:289-293.
36. 1. J Interferon Res 1989;9:245-257.
37. Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-n: an overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-189.
38. Gaertner FH, Babiuk LA, Mutwiri G, et al. Amended recombinant cells (ARC) expressing bovine IFN-gamma;: an economical and highly effective adjuvant system. Vaccine 2009;27:1377-1385.